Pure Extracts Advances Plans for the Processing of Functional Mushroom Formulations
November 26, 2020
Ryan Allway November 26th, 2020 App, Psychedelics, Top News VANCOUVER, British Columbia, Nov. 26, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp . (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sectors, is pleased... Read more
Ryan Allway November 25th, 2020 App, Psychedelics, Top News There is a global resurgence in the interest in psychedelics. With scientific, medical, and mental health communities revisiting its potential therapeutic benefits, psychedelics are being touted for its potential to treat addictions, mental health, cancer, amongst other ailments. This year... Read more
Psychedelic-Focused Media, E-Commerce and Event Company Delic Holdings to Begin Trading on the Canadian Securities Exchange Under the Ticker Symbol “DELC”
November 24, 2020
Ryan Allway November 24th, 2020 Psychedelics Delic Holdings Inc. (“ DELIC ” or the “ Company ”), a psychedelic-focused media, e-commerce and event company, is pleased to announce that effective at market open today, the Company will begin trading on the Canadian Securities Exchange under the ticker symbol “DELC.”... Read more
Havn Life Sciences Announces $5.46 Million Warrant Exercise
November 24, 2020
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
PharmaDrug Positions for Eurozone Psychedelic Distribution as Germany Begins Psilocybin Depression Study
November 24, 2020
Toronto, Ontario–(Newsfile Corp. – November 23, 2020) – Pharmadrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“) applauds the recent approval by Germany’s Federal Institute of Drugs and Medical Devices (BfArM) of a study examining the Efficacy and Safety of Psilocybin in Treatment-Resistant Depression. This marks the... Read more
Red Light Holland and Halo Labs Announce Intention to Enter Oregon Medicinal Psilocybin Market
November 20, 2020
“Clearly, we are very excited with the recent results of Oregon Measure 109 where progressive Oregonians have voted in favor of becoming the first state in the US, to allow the use of psilocybin, for therapeutic use. We take pride at Red Light Holland in our self-regulated responsible adult... Read more
Field Trip Health Ltd. and WHOOP announce partnership to measure effect of psychedelic therapies on physiology and mental health
November 19, 2020
Ryan Allway November 19th, 2020 Psychedelics Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF) (“Field Trip”), a global leader in the development and delivery of psychedelic therapies, and WHOOP, the human performance company, today announced a partnership whereby Field Trip will be using WHOOP Strap 3.0 to measure the... Read more
Mind Cure Announces Closing of Oversubscribed $3.6 Million Offering
November 19, 2020
Ryan Allway November 19th, 2020 Psychedelics Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“Mind Cure”or the “Company”) is pleased to announce that is has closed, on an oversubscribed basis, its previously announced non-brokered private placement (the “Offering“). The Company issued 8,000,000 units (the “Units“) at a... Read more
NeonMind Commences Preclinical Trial to Examine Psilocybin for Weight
November 19, 2020
Ryan Allway November 19th, 2020 Psychedelics, Top News Vancouver, B.C. – November 19, 2020: Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) is pleased to announce that its majority owned subsidiary NeonMind Biosciences Inc. (“NeonMind”) has now commenced a psilocybin preclinical trial examining psilocybin... Read more
Lobe Sciences Commences Trading Under New Name and Announces Rebranding and Corporate Update
November 16, 2020
Ryan Allway November 16th, 2020 Psychedelics, Top News Lobe Sciences unveils new corporate name and logo as part of an extensive rebranding initiative, reflective of the Company’s focus on psychedelic medicines Vancouver, British Columbia–(Newsfile Corp. – November 16, 2020) – Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe”... Read more
